The therapeutic potential of κ-opioids for treatment of pain and addiction.
Department of Pharmacology, University of Washington School of Medicine, Seattle, WA, USA. cchavkin@u.washington.edu
Charles
C
Chavkin
D000818:Animals; D001008:Anxiety Disorders / Q000188:drug therapy / Q000378:metabolism; D006801:Humans; D009292:Narcotic Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D009293:Opioid-Related Disorders / Q000188:drug therapy / Q000378:metabolism / Q000517:prevention & control; D010146:Pain / Q000188:drug therapy* / Q000378:metabolism; D017473:Receptors, Opioid, kappa / Q000819:agonists / Q000037:antagonists & inhibitors* / Q000502:physiology; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D013315:Stress, Psychological / Q000188:drug therapy* / Q000378:metabolism; D019966:Substance-Related Disorders / Q000188:drug therapy* / Q000378:metabolism
D009292:Narcotic Antagonists; D017473:Receptors, Opioid, kappa